Attached files
| file | filename |
|---|---|
| EX-99.3 - EXHIBIT 99.3 - Modular Medical, Inc. | ex99_3.htm |
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, DC 20549
FORM 8-K/A
CURRENT REPORT
Pursuant to Section 13 or 15(d) of
the Securities Exchange Act of 1934
July 24, 2017
| Date of Report (date of earliest event reported) |
Modular Medical, Inc.
| (Exact name of Registrant as specified in its charter) |
| Nevada | 000-49671 | 87-0620495 | ||
| (State
or other jurisdiction of incorporation or organization) |
(Commission File Number) | (I.R.S.
Employer Identification Number) |
17995 Bear Valley Lane
Escondido CA 92027
| (Address of principal executive offices) |
949 370-9062
| (Registrant’s telephone number, including area code) |
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
| o | Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
| o | Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
| o | Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
| o | Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company o
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. o
Explanatory Note
This amendment is being filed to include exhibit 99.3, the financial statements of Quasuras, Inc., for the quarter ended June 30, 2017.
ITEM 9.01 FINANCIAL STATEMENTS AND EXHIBITS
(a) Financial Statements of Quasuras, Inc. for the quarter ended June 30, 2017
| Exhibit | |
| Number | Exhibit Title |
| 99.3 | Financial statements for the quarter ended June 30, 2017. |
| 2 |
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
| Modular Medical, Inc. | ||
| Date: September 21, 2017 | By: | /s/ Paul M. DiPerna |
| Paul DiPerna | ||
| Chief Executive Officer | ||
| 3 |